| Title | Wearable Injectors Market worth $15.1 billion by 2029 |
|---|
| URL | https://www.abnewswire.com/pressreleases/wearable-injectors-market-worth-151-billion-by-2029_703111.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Global Wearable Injectors Market, Wearable Injectors Industry, Wearable Injectors Market Size, Wearable Injectors Market Outlook |
|---|
| Meta Description | Amgen Inc. (US), Medtronic PLC (Europe), Insulet Corporation (US), Tandem Diabetes Care, Inc. (US), United Therapeutics Corporation (US), Abbvie Inc. (US), Gerresheimer AG (Germany) |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| Wearable Injectors Market in terms of revenue was estimated to be worth $8.4 billion in 2023 and is poised to reach $15.1 billion by 2029, growing at a CAGR of 10.3% from 2023 to 2029 according to a new report by MarketsandMarketsâ„¢. |
